Terbinafine - Novartis
Alternative Names: DermGel; Lamisil; Ramicil; SDZ SF86327; SF 86327Latest Information Update: 25 Sep 2021
At a glance
- Originator Novartis
- Class Amines; Antifungals; Naphthalenes; Skin disorder therapies; Small molecules
- Mechanism of Action Squalene monooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Mycoses; Pityriasis versicolor; Tinea capitis; Tinea corporis; Tinea cruris; Tinea pedis
Most Recent Events
- 09 Jun 2010 Generic equivalent approved in USA
- 28 Sep 2007 Launched for Tinea capitis in USA (PO)
- 28 Sep 2007 Registered for paediatric Tinea capitis in USA (PO)